Washington, DC—Legislators on Capitol Hill heard first-hand how their funding of National Eye Institute (NEI) research is advancing the understanding of age-related macular degeneration (AMD).
OcuDyne completes successful pilot study of OPTiC System
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Study: 100x improvement in sight detected after gene therapy trial
Advancing the optimal diagnosis & treatment of thyroid eye disease
Viridian announces positive topline data from phase 3 THRIVE trial evaluating veligrotug in patients with active TED
Retina Society 2024: Aura Biosciences reports positive Phase 2 end of study results evaluating AU-011 for early-stage choroidal melanoma